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Abstract

Keywords: Cardiac magnetic resonance; Fractional flow reserve;
Coronary stenosis

Background: Fractional flow reserve (FFR) is considered the gold
standard for diagnosis of coronary artery disease (CAD). Stress Cardiac magnetic resonance (SCMR) has been recently gaining traction
as a non-invasive alternative to FFR.
Methods: Studies comparing the diagnostic accuracy of SCMR versus FFR were identified and analyzed using Review Manager (RevMan) 5.3 and Stata software.
Results: A total of 28 studies, comprising 2,387 patients, were included. The pooled sensitivity and specificity for SCMR were 86% and
86% at the patient level, and 82% and 88% at the vessel level, respectively. When the patient-level data were stratified based on the FFR
thresholds, higher sensitivity and specificity (both 90%) were noted
with the higher cutoff (0.75) and lower cutoff (0.8), respectively. At
the vessel level, sensitivity and specificity at the lower FFR threshold
were significantly higher at 88% and 89%, compared to the corresponding values for higher cutoff at 0.75. Similarly, meta-regression
analysis of SCMR at higher (3T) resolution showed a higher sensitivity of 87% at the patient level and higher specificity of 90% at the
vessel level. The highest sensitivity and specificity of SCMR (92%
and 94%, respectively) were noted in studies with CAD prevalence
greater than 60%.
Conclusions: SCMR has high diagnostic accuracy for CAD comparable to FFR at a spatial resolution of 3T and an FFR cut-off of 0.80.
An increase in CAD prevalence further improved the specificity of
SCMR.
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Introduction
The interpretation of invasive coronary angiography (ICA)
based on anatomic reference standard has been the sole diagnostic modality for coronary artery disease (CAD) for a long
time [1]. However, fractional flow reserve (FFR) and stress
cardiac magnetic resonance (SCMR) are now coming into
more frequent use. Recent studies have demonstrated the discordance between FFR and ICA, especially at the extremes of
the angiographic spectrum (stenosis less than 30% or greater
than 90%) [1]. Thus, an assumption of functional relevance
based merely on the angiographic appearance of stenosis in
the absence of FFR can be misleading. FFR appears to be more
precise for the depiction of lesion-specific ischemia but at the
cost of radiation exposure and an invasive procedure. SCMR
perfusion scans have been suggested as an alternative to guide
clinical decision-making, particularly in cases of CAD with
stenosis of 50-75% [2]. Our study adds to the existing literature by pooling all available data to determine the diagnostic
accuracy of SCMR for diagnosing CAD severity when compared to the gold-standard FFR.

Materials and Methods
Search strategy
A literature search for relevant articles was performed using
PubMed, Ovid, Embase, clinicaltrials.gov, and Cochrane databases. There was no language or time restriction. The search
strategies included various combinations of text-words and
medical subject headings (MeSH) to generate two subsets
of citations: one for magnetic resonance imaging using the
terms such as “MRI”, “magnetic resonance imaging”, “magnetic resonance perfusion”, “cardiac MRI”, “SCMRI”, “MR
perfusion imaging”; the other for fractional flow reserve using
terms such as “FFR”, “fractional flow reserve”, “flow reserve”,
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“coronary flow reserve”, and “coronary pressure reserve”. The
terms from the two subsets were combined in 1:1 combination
using Boolean operators; and finally, results from all the possible combinations were downloaded into an EndNote library.
Based on our research question, articles from the reference
lists relevant to the clinical question were screened by an independent author.
Selection criteria and study collection
All observational (retrospective/prospective) studies and randomized control trials (RCT) on SCMR and FFR till September
30, 2019, were evaluated. Articles comparing the diagnostic
accuracy of SCMR perfusion scan with FFR were included in
the study. Papers with insufficient data, review articles, case
reports, editorials, and conference papers were excluded.
Data extractions
Three authors independently screened titles and abstracts of all
articles for relevance. A fourth author selected articles that met
inclusion criteria. The full texts of articles that were potentially relevant to the study were screened by all the four authors
to confirm eligibility. Baseline characteristics of the included
population were reviewed, and data were collected for quality
assessment to ensure study cohorts were statistically comparable. Risk factors for CAD, such as hypertension (HTN), hyperlipidemia (HLD), smoking, diabetes mellitus (DM), prior
myocardial infarction (MI) and prior CAD were compared in
each group of the included study to ensure comparability of
the included population. Data were extracted into a combined
Excel sheet. Disagreements were resolved by mutual consensus and after group discussion. The primary outcome was to
determine the diagnostic accuracy of SCMR versus FFR for
CAD severity.
Data and quality analysis
Raw data regarding the true and false positives and true and
false negatives of each included study were obtained; and the
combined measures of test accuracy (i.e., sensitivity, specificity, and diagnostic odds ratio (DOR)) for SCMR perfusion were
calculated, keeping FFR as a standard. A bivariate model was
obtained from data fitting. The parameters from the bivariate
model were transformed into hierarchical summary receiver
operating characteristic (HSROC) estimates. The area under
the summary HSROC curve (AUC) was calculated to reveal
the probability of accurately ranked diagnostic test values for
a random pair of subjects (one with disease and one without
disease). Chi-squared (χ2) tests were conducted to evaluate the
heterogeneity of sensitivities and specificities among all studies. Subgroup analysis based on the resolution of SCMR and
FFR cutoff points was performed to explore the potential heterogeneity factors using subgroup and meta-regression analysis. The statistical analysis was performed using the diagnostic
146
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Figure 1. Overall risk of bias on the QUADAS-2 tool of the included
studies in our study. QUADAS-2: the Quality Assessment of Diagnostic
Accuracy Studies.

accuracy statistical model on Stata and R mad package.
Quality of included studies
Quality of the included studies was assessed for potential bias
and applicability concerns using the Quality Assessment of
Diagnostic Accuracy Studies (QUADAS-2) standard questionnaire. The overall risk of bias and applicability concerns based
on patient selection, index and reference standard, and the time
duration between these tests were of low concern. Approximately 40% of studies either did not mention the duration or
had more than 4 weeks difference between the aforementioned
diagnostic tests. Only one study (Schuchlenz et al) had insufficient bias assessment data posing a 3% unknown bias risk to
the index and reference standard tests [3] (Fig. 1). Twenty-five
percent of the studies did not specify the baseline characteristics of its subjects and were stratified under the high-risk selection bias group (Fig. 2).

Results
Search results and study characteristics
The initial search revealed 3,921 articles. After the removal
of irrelevant and duplicate items, 238 articles were deemed
relevant for full-text review. We further excluded 210 articles
based on our selection criteria; and 28 studies were included
for final analysis [3-30]. The preferred reporting items for systematic review and meta-analysis (PRISMA) flow diagram are
shown in Figure 3.
A total of 2,387 patients and 3,936 coronary vessels were
included [3-30]. Mean age was 63 years. Seventeen studies
used 0.8, and 11 articles used 0.75 as FFR cutoff. Studies using
both 1.5T (18) and 3.0T (10) SCMR spatial resolution were
included. Semi-quantitative data analysis was employed in 10
studies, quantitative in nine studies, while the method of data
analysis was not specified in the remainder. A time interval of 4
weeks or less was present between SCMR and FFR in 16 of the
included studies, more than 4 weeks in three studies, and not
specified in eight studies. Subjects included in all the available
studies had a variable prevalence of the baseline characteristics and comorbidities, including prior MI, CAD, DM, HTN,
multivessel disease, and smoking. The detailed characteristics
of the included studies are summarized (Supplementary Material 1, www.cardiologyres.org).
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Figure 3. PRISMA flow diagram showing the selection of studies from
all databases. PRISMA: preferred reporting items for systematic review
and meta-analysis.

b). The DOR on a per-patient basis was 48.5 (95% CI, 23.52 100.41). The absolute AUC was 0.91, while partial AUC was
0.78 (Fig. 5). The test for equality of sensitivities showed moderate to severe heterogeneity I2 = 88% (χ2 = 137.17, df = 16, P
value ≤ 2 × 10-16), while moderate heterogeneity was observed
among the studies selected for equality of pooled specificities
I2 = 66% (χ2 = 50.59, df = 16, P value = 1.85 × 10-5).
Coronary-territory pooled diagnostic accuracy

Figure 2. Risk of bias on the QUADAS-2 tool of the individual studies
included in our meta-analysis. QUADAS-2: the Quality Assessment of
Diagnostic Accuracy Studies.

Patient-level pooled diagnostic accuracy
At the patient level, pooled sensitivity and specificity for perfusion SCMR were 0.86 (95% confidence interval (CI), 0.79
- 0.91) and 0.86 (95% CI, 0.82 - 0.90), respectively (Fig. 4a,

At vessel level, SCMR showed an overall sensitivity of 0.82
(95% CI, 0.76 - 0.88), and specificity of 0.88 (95% CI, 0.84 0.94) compared to FFR (Fig. 6a, b). The absolute AUC, partial
AUC and DOR were 0.91, 0.85 and 37.95 (95% CI, 22.60 63.73), respectively (Fig. 7). The test for equality of diagnostic
accuracy showed moderate to severe heterogeneity among the
studies selected for sensitivity (I2 = 89%, χ2 = 204.5, df = 21, P
≤ 2 × 10-16), and specificity (I2 = 85%, χ2 = 142.9, df = 21, P ≤
2 × 10-16).
Subgroup analysis based on FFR threshold
Pooled diagnostic accuracy was stratified based on the two
reported FFR thresholds. At the vessel level, sensitivity and
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Figure 4. (a) Forest plot depicting individual and pooled sensitivity at the patient level. (b) Forest plot depicting individual and
pooled specificity at the patient level.

specificity at the lower FFR threshold (0.8) were significantly
higher at 0.88 (95% CI, 0.84 - 0.91) and 0.89 (95% CI, 0.82
- 0.93), compared to 0.80 (0.68 - 0.88) and 0.87(0.82 - 0.91)
for FFR at the higher threshold (0.75) (Supplementary Material 2, www.cardiologyres.org). The DOR of FFR at the higher
threshold was only 29.71, almost half of the DOR for the lower
(0.80) cutoff (62.37 (95% CI, 32 - 118).
At the patient level, however, the higher cutoff exhibited
a higher net sensitivity, 0.90 (95% CI, 0.84 - 0.94) but lower
specificity 0.82 (95% CI, 0.73 - 0.88) compared to the lower
cutoff, where the sensitivity was 0.85 (95% CI, 0.76 - 0.91)
and specificity was 0.90 (95% CI, 0.84 - 0.93) (Supplementary
Material 3, www.cardiologyres.org). The overall DOR favored
the lower FFR threshold (52.3, 95% CI, 20.81 - 131.47) vs.
(43.96, 95% CI, 18.98 - 101.84).
Subgroup analysis based on SCMR resolution
At vessel level, the specificity of SCMR at higher resolution
148

(0.90, 95% CI 0.866 - 0.93) was significantly greater compared
to lower resolution (0.85, 95% CI, 0.79 - 0.89) (Supplementary Material 4, www.cardiologyres.org), while the sensitivity
was marginally higher for the lower resolution (0.85 vs. 0.81).
The overall DOR was superior for higher resolution SCMR
(44, 95% CI, 20 - 95) compared to (33, 95% CI, 16 - 66) for
1.5T SCMR. At the patient level, the sensitivity and specificity
were comparable at both resolutions (Supplementary Material
5, www.cardiologyres.org).
Meta-regression analysis based on comorbidities
Meta-regression analysis based on covariates such as age
(higher or lower than 65 years) and CAD prevalence were
performed. SCMR had high sensitivity and specificity at
0.92 and 0.94, respectively, for studies with CAD prevalence
greater than 60%, compared with the sensitivity of 0.83, and
specificity of 0.84 with prevalence of CAD less than 60%
(Supplementary Material 6, www.cardiologyres.org). Corre-

Articles © The authors | Journal compilation © Cardiol Res and Elmer Press Inc™ | www.cardiologyres.org

Ullah et al

Cardiol Res. 2020;11(3):145-154

Figure 5. Patient-level pooled diagnostic accuracy of CMR associated
HROC vessel. CMR: cardiac magnetic resonance; HROC: hierarchical
summary receiver operating characteristic.

sponding values at the vessel level were lower (Supplementary Material 6, www.cardiologyres.org). For both younger
and older populations, the SCMR sensitivity was 0.86, but a
higher specificity was noted for the younger population (0.89
vs. 0.81) (Table 1). A comparison of patient and vessel level
data has been shown in Supplementary Material 7 (www.cardiologyres.org).

Discussion
If proven to have similar diagnostic efficacy, SCMR would
be favorable to the current reference standard (FFR) due to
its non-invasive nature, zero radiation exposure, and lower
attenuation artifacts. Although myocardial perfusion SCMR
has been possible for many years, the clinical sequence and
data processing remain variable between centers. Our metaanalysis estimated the diagnostic performance of perfusion
SCMR in patients with known or suspected CAD and focused on comparing diagnostic accuracies at varying spatial
resolution and FFR thresholds. Our results reconcile the varying findings of previous studies and show high diagnostic
accuracy of SCMR perfusion using FFR as a reference at patient level, with a sensitivity of 0.86 and specificity of 0.86.
Subgroup analysis for the FFR threshold of lower (0.8) compared to higher (0.75) showed better sensitivity and specificity (about 90%) for the former. Further analysis showed that

for higher spatial resolution of SCMR (3.0T), the sensitivity
and specificity were also greater at 87% and 90%, respectively.
FFR is calculated as the ratio of hyperemic pressure difference across coronary lesions compared to theoretical maximum flow in healthy coronary arteries [31]. FFR is considered
the gold standard and has been proven to improve event-free
survival in coronary revascularization [32]. However, for all
its benefits, it has yet to gain widespread acceptance due to the
invasive nature of the procedure [32]. As mentioned above,
SCMR perfusion imaging, which is a non-invasive procedure,
would seek to allay the concerns around the risks of FFR while
offering a similar diagnostic profile. Interpretation is based on
coronary flow reserve (CFR), which is driven by the pressure
gradient between systemic diastolic and left ventricular enddiastolic pressure at maximal vasodilation and under medication-induced stress. With vasodilator CMR (particularly using
regadenoson, the most commonly used vasodilator currently),
the perfusion defects are related to relative differences in blood
flow between myocardium subtended by normal vs. stenotic
coronary arteries [31]. The percentage of the ischemic territory
serves as an indirect indicator of coronary artery stenosis, and
is correlated against the findings of FFR [32].
On review of previously published meta-analyses, we
noticed inconsistencies in the number of included studies.
More contemporary studies did not always include all previously published data and had additional limitations due to
outcome biases [2, 33-37]. Studies more stringent in their inclusion criteria, perhaps overestimated the diagnostic accuracy of SCMR owing to a positive selection bias. Danad et al
(2016, four studies) reported a patient-based SCMR accuracy
of greater than 90%; however, this was found to be lower at
87% in a 2019 study by Yang et al, which included a much
higher number of studies (19) [2, 36]. Vessel-level sensitivity analysis showed a similar discordance across all included
studies. A common limitation observed was a lack of stratification based on the different diagnostic thresholds for SCMR
perfusion scans and FFR [34-37]. The study of Desai et al was
the only one that used an FFR diagnostic threshold of 0.75
as opposed to the standard 0.80, hampering the sensitivity of
the SCMR perfusion scan by classifying a significant population of patients having FFR of 0.75 - 0.80 as falsely “normal”
[33]. Similarly, many included studies used 40-80% stenosis
as inclusion criteria for stable CAD, when compared to the
standard criteria of 50-75% stenosis. This would falsely classify subjects as having CAD compromising the sensitivity of
SCMR (Table 2, [2, 33-37]). Moreover, differences in the contrast used across the studies also undermined the results; a few
authors used exogenous contrast for stress images, while others advocated the utilization of the paramagnetic properties
of deoxyhemoglobin as an endogenous contrast to identify
loss of T2 flair in the blood oxygen level-dependent (BOLD)
SCMR [36].
We aimed to close the gap in clinical practice and obtain
consensus on the preferred approach towards the diagnosis of
CAD severity, by performing a comprehensive analysis of all
available data to address the aforementioned limitations.
The objective was to compare the efficacy of two investigative strategies for the management of patients with suspected
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Figure 6. (a) Forest plot depicting individual and pooled sensitivity at the vessel level. (b) Forest plot depicting individual and
pooled specificity at the vessel level.

CAD at the level of both higher and lower FFR thresholds and
SCMR spatial resolution. Our overall results indicate that at a
lower FFR threshold and higher spatial resolution, SCMR perfusion is comparable to invasive angiography supplemented
by FFR measurements in guiding the management of patients
with stable CAD. Our subgroup analyses showed a 4% rise in
the vessel-level specificity of SCMR with an increase in its
resolution from 1.5T to 3.0T and an 8% increase in specificity with the decreasing FFR threshold from 0.75 to 0.80. This
improves the detection ability of SCMR perfusion to identify subendocardial ischemia. It also enables the detection of
stress-mediated regional wall motion abnormalities at an earlier stage [36]. Given the comparable accuracy of SCMR perfusion scan to the current invasive reference standard (FFR),
SCMR should be seen as an attractive non-invasive alternative
to current diagnostic approaches.
This meta-regression analysis showed that sensitivity and
specificity of SCMR differed among populations with differing
pre-test probability of CAD, indicating patient selection based
150

on presentation and risk stratification is essential. In the high
prevalence group, SCMR findings were equivalent to FFR,
and overall specificity was high at 94%. In these selected patients, SCMR can serve as a non-invasive substitute for FFR
without significant loss in diagnostic accuracy. Interestingly,
meta-regression based on age cutoff of 65 years showed similar sensitivity but an 8% lower specificity in the older population. One can argue that microvascular disease as a result of
advancing age, smoking, and atherosclerosis can potentially
affect SCMR perfusion imaging more than the FFR, and can
have a detrimental effect on diagnostic accuracy. Stress CMR
perfusion defects can be due to epicardial CAD and/or microvascular CAD. FFR on the other hand can be falsely in the
“normal” range because of severe microvascular CAD, even
in the presence of epicardial CAD. Thus, stress CMR is arguably more sensitive because unlike FFR, it “accounts for” the
possibility of microvascular CAD, and the diagnostic accuracy
comparisons may actually be affected because of a flawed reference standard (FFR).
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Limitations
A few of the included studies performed a direct comparison
of SCMR perfusion scan with FFR, an observation that may
underscore the restricted availability of SCMR to advanced
centers. Paradoxically, a lower rate of diagnostic accuracy is
expected when SCMR becomes more widely available, leading to possible imprudent use.
We believe that the conceptual differences between these
tests are irrefutable. FFR assumes static endothelial function
on either side of the coronary lesion and an intact microcirculation. Thus, findings are reliable in large coronary arteries but are
often underappreciated in microcirculation. In contrast, SCMR
assesses the coronary vasculature in its entirety. FFR identifies
the hemodynamic significance and functional relevance of coronary lesions, but gives no direct indication of the size of territory
at risk of ischemia or its viability. SCMR, on the other hand,
is a surrogate marker of coronary stenosis, an indirect measure
of the degree of functional and anatomic coronary compromise
based on the identification of myocardial ischemia. This technical discrepancy poses some theoretical risk of inconsistency and
unreliability between the two diagnostic modalities.
Conclusions

Figure 7. Vessel-level pooled diagnostic accuracy of CMR associated
HROC. CMR: cardiac magnetic resonance; HROC: hierarchical summary receiver operating characteristic.

SCMR can be used as a confirmation test for patients with a
high pretest probability of CAD and as an exclusionary test
for low-risk patients due to its high specificity and sensitivity compared to FFR, respectively. A lower FFR threshold of

Table 1. Meta-Regression Analysis on the Basis of CAD Prevalence and Age of the Patients in Included Studies
Variable

Sensitivity (95% CI)

Specificity (95% CI)

DOR

Vessel level, MI > 60%

0.84 (0.77 - 0.88)

0.86 (0.81 - 0.89)

32 (19 - 53)

Patient, MI > 60%

0.92 (0.88 - 0.94)

0.94 (0.92 - 0.96)

12 (10 - 33)

Vessel level, MI < 60%

0.81 (0.66 - 0.91)

0.88 (0.82 - 0.92)

34 (14 - 80)

Patient, MI < 60%

0.82 (0.74 - 0.89)

0.84 (0.81 - 0.87)

27 (15 - 50)

Vessel level, Age < 65

0.82 (0.74 - 0.88)

0.89 (0.85 - 0.92)

34 (14 - 80)

Patient, Age < 65

0.86 (0.79 - 0.91)

0.89 (0.85 - 0.93)

58 (26 - 126)

Vessel level, Age > 65

0.86 (0.71 - 0.94)

0.81 (0.72 - 0.88)

28 (12 - 67)

CAD: coronary artery disease; MI: myocardial infarction; 95% CI: 95% confidence interval; DOR: diagnostic odds ratio.

Table 2. Characteristics, Outcomes and Limitations of Previously Reported Meta-Analyses
Author

Studies included

Desai et al, 2013 [33]

Sensitivity, specificity

Limitation

Patient level

Vessel level

12

89.1%, 84.9%

87.7%, 88.6%

Used 0.75 only

Li et al, 2014 [34]

14

90%, 87%

89%, 86%

No stratification based on thresholds

Jiang et al, 2016 [35]

20

88%, 88%

86%, 88%

No stratification based on thresholds

Danad et al, 2017 [36]

4

90%, 94%

91%, 85%

No stratification based on thresholds

Dai et al, 2016 [37]

21

88%, 84%

87%, 89%

No stratification based on MRI thresholds

Yang et al, 2019 [2]

19

87%, 87%

85%, 89%

CAD 50-75%

CAD: coronary artery disease.
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0.8 and a higher SCMR resolution of 3.0T, in particular, were
associated with the highest diagnostic accuracy. SCMR represents advances over FFR in the detection of CAD severity, due
to its non-invasive nature, being readily available and offering
a comparable sensitivity and specificity.

Supplementary Material
Suppl 1. Characteristics of Included Studies.
Suppl 2. HROC for FFR of 0.75 and 0.8 at the vessel level.
Suppl 3. HROC for FFR of 0.75 and 0.8 at the patient level.
Suppl 4. HROC for CMR at vessel level at spatial resolution
of 1.5T and 3T.
Suppl 5. HROC for CMR at patient level at spatial resolution
of 1.5T.
Suppl 6. Meta-regression based on the prevalence of MI <
60% at the patient level, MI > 60% at the vessel level, and MI
< 60% at the vessel level.
Suppl 7. Meta-regression based on the age < 65 at the patient
level, < 65 at the patient level, and > 65 at the vessel level.
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study are available within the article.
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CMR: cardiac magnetic resonance; CAD: coronary artery disease; FFR: fractional flow reserve
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